Medical Director
Deciphera Pharmaceuticals
Medical Director
Deciphera Pharmaceuticals
Develops kinase inhibitors for cancer.
The medical director will provide clinical development leadership at the study level for one or more clinical stage assets in early and/or late development. To achieve development goals this individual will foster collaboration with allied functions through outstanding communication, collaboration and coordination. Depending on business needs, the role could include mentorship and management of one or more clinical scientists as well as contribution to business development and continuous improvement activities.
Key Responsibilities:
Preferred Capabilities
Deciphera is committed to fair and equitable compensation practices. The base salary pay range for this role is $248,000-$341,000. Actual compensation packages will depend on various factors, including, but not limited to depth of experience, education, skillset, overall performance and/or location.
Deciphera believes in providing a competitive compensation and benefits package to all employees. Our base salary is just one component of Deciphera’s competitive total rewards strategy that also includes annual performance bonus, a long-term incentive plan, full range of benefits and other incentive compensation plans (if applicable)
Benefits:
EQUAL EMPLOYMENT OPPORTUNITY INFORMATION
Deciphera is committed to equal employment opportunity and values diversity. To ensure that we comply with reporting requirements, we invite you complete the confidential survey at the end of this application. Providing this information is optional. It will not be accessible or used in the hiring process, and has no effect on your opportunity for employment. This information will also be treated confidentially. We are committed to make all hiring decisions and other employment decisions on a non-discriminatory basis.
Develops kinase inhibitors for cancer.
Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing cancer medicines. It uses a proprietary switch-control kinase inhibitor platform and deep kinase biology expertise to create targeted therapies for various cancers. The company advances drug candidates through research, clinical trials, and regulatory approval, then brings approved medicines to market and seeks partnerships or licensing deals to expand its reach. Its competitive edge comes from its unique switch-control kinase inhibitors and deep biology know-how, which aim to deliver precision treatments in oncology. The company’s goal is to improve the lives of cancer patients by delivering effective targeted therapies.
Explore more opportunities at Deciphera Pharmaceuticals